Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMPRSS15 | SNV | Missense_Mutation | | c.329N>C | p.Arg110Thr | p.R110T | P98073 | protein_coding | tolerated(0.06) | benign(0.018) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
TMPRSS15 | SNV | Missense_Mutation | | c.1517T>A | p.Leu506His | p.L506H | P98073 | protein_coding | tolerated(0.55) | possibly_damaging(0.45) | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.158G>C | p.Gly53Ala | p.G53A | P98073 | protein_coding | tolerated(0.11) | benign(0.009) | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.977G>A | p.Gly326Asp | p.G326D | P98073 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMPRSS15 | SNV | Missense_Mutation | novel | c.1885N>A | p.Ala629Thr | p.A629T | P98073 | protein_coding | deleterious(0.04) | probably_damaging(0.936) | TCGA-AC-A62Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.65N>T | p.Ala22Val | p.A22V | P98073 | protein_coding | tolerated(0.28) | benign(0.007) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.329N>C | p.Arg110Thr | p.R110T | P98073 | protein_coding | tolerated(0.06) | benign(0.018) | TCGA-D8-A27I-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adrimycin+cyclophosphamide | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.236N>T | p.Ser79Leu | p.S79L | P98073 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A27T-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicine+cyclophosphamide | SD |
TMPRSS15 | SNV | Missense_Mutation | | c.2581N>A | p.Glu861Lys | p.E861K | P98073 | protein_coding | deleterious(0.03) | benign(0.006) | TCGA-GM-A2DO-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | CR |
TMPRSS15 | SNV | Missense_Mutation | novel | c.1835N>G | p.Met612Arg | p.M612R | P98073 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-LL-A5YO-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | THONZONIUM BROMIDE | THONZONIUM BROMIDE | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US9024044, 62 | | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | CALMIDAZOLIUM CHLORIDE | CALMIDAZOLIUM CHLORIDE | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | NSC-60340 | CHEMBL1534034 | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US9024044, 3 | | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US9346821, B-13 | | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US8609715, A-1 | | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US8609715, A-26 | | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | GNF-PF-254 | CHEMBL461579 | |
5651 | TMPRSS15 | PROTEASE, DRUGGABLE GENOME, ENZYME | | US8609715, B-61 | | |